Back to Authors

Zeng, Hu

https://orcid.org/0000-0002-9909-7732

Mayo Clinic

Mayo Clinic

Citations 35

Aging T cells portend poor outcome in follicular lymphoma
Zeng, Hu

Science Translational Medicine | March 7, 2019 | Volume: 11 | Issue: 482 | Pages: No page available

10.1126/scitranslmed.aaw7628 Get It

Immune cell profiling identifies intratumoral T cell subsets associated with patient survival in follicular lymphoma.
Interfer-ing with immunotherapy-induced autoimmunity
Zeng, Hu

Science Translational Medicine | January 10, 2019 | Volume: 11 | Issue: 474 | Pages: No page available

10.1126/scitranslmed.aaw0533 Get It

Inhibition of type I IFN prevents autoimmune toxicity while preserving antitumor efficacy of combined cancer vaccine and adoptive cell therapy.
Exploiting human T regs ’ sweet tooth to improve cancer immunotherapy
Zeng, Hu

Science Translational Medicine | November 7, 2018 | Volume: 10 | Issue: 466 | Pages: No page available

10.1126/scitranslmed.aav6058 Get It

TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.
A fatty link between heart disease and autoimmunity
Zeng, Hu

Science Translational Medicine | May 23, 2018 | Volume: 10 | Issue: 442 | Pages: No page available

10.1126/scitranslmed.aat8535 Get It

Atherogenic hyperlipidemia drives IL-27 production by dendritic cells to support follicular T cell differentiation and systemic autoimmune disorders in mice.
Double safety reins in wayward B cells
Zeng, Hu

Science Translational Medicine | March 28, 2018 | Volume: 10 | Issue: 434 | Pages: No page available

10.1126/scitranslmed.aat3886 Get It

Two regulatory proteins suppress IRF5 transcription factor in age-associated B cells to prevent systemic autoimmune disorders.